The co-existence of various cellular and molecular processes within a tumor mass has led the research towards identification of key molecules in the autophagy/apoptosis switch (Beclin1, Caspase, p53, PI3K/AKT/mTOR, and p62), which is useful for planning anti-cancer target therapies [119,120]. The gene discussed is BECN1; the disease is neoplasm.